Rite Aid 2011 Annual Report Download - page 22

Download and view the complete annual report

Please find page 22 of the 2011 Rite Aid annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 119

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119

medicines to our pharmacies, and whether any customers who receive federally funded prescription
benefits (e.g. Medicare and Medicaid) may have benefited from those programs. We are in the process
of producing records in response to the subpoena and are unable to predict with certainty the timing or
outcome of the investigation.
We do not believe that any of these matters will have a material adverse effect on our business or
financial condition. We cannot give assurance, however, that an unfavorable outcome in one or more of
these matters will not have a material adverse effect on our results of operations for the period in
which they are resolved.
We are subject from time to time to various claims and lawsuits and governmental investigations
arising in the ordinary course of our business. While our management cannot predict the outcome of
these claims with certainty, our management does not believe that the outcome of any of these legal
matters will have a material adverse effect on our business, consolidated results of operations or
financial position.
Item 4. Removed and Reserved
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuers Purchases
of Equity Securities.
Our common stock is listed on the NYSE under the symbol ‘‘RAD.’’ On April 15, 2011, we had
approximately 26,643 stockholders of record. Quarterly high and low closing stock prices, based on the
composite transactions, are shown below.
Fiscal Year Quarter High Low
2012 (through April 15, 2011) ...................... First $1.31 $0.98
2011 ........................................ First 1.74 1.08
Second 1.18 0.88
Third 1.10 0.87
Fourth 1.41 0.88
2010 ........................................ First 1.22 0.21
Second 1.74 1.22
Third 2.24 1.26
Fourth 1.66 1.26
We have not declared or paid any cash dividends on our common stock since the third quarter of
fiscal 2000 and we do not anticipate paying cash dividends on our common stock in the foreseeable
future. Our senior secured credit facility and some of the indentures that govern our other outstanding
indebtedness restrict our ability to pay dividends.
We have not sold any unregistered equity securities during the period covered by this report, nor
have we repurchased any equity securities, during the period covered by this report.
Our Chief Executive Officer certified to the NYSE on June 29, 2010 that he was not aware of any
violation by the Company of the NYSE’s corporate governance listing standards.
22